Hot Stocks to Watch for Friday, April 28, 2006: Patent Protection for Core Drug Discovery and Toxicology Platform!

TheSUBWAY.com announces the following stocks to its Hot Stocks List: Stem Cell Innovations, Inc. (OTC BB: SCLL), Conexant Systems, Inc. (NASDAQ: CNXT), Intuitive Surgical, Inc. (NASDAQ: ISRG), Nektar Therapeutics (NASDAQ: NKTR).

Stem Cell Innovations, Inc. (OTC BB: SCLL) has filed a patent application protecting the differentiation of its proprietary human pluripotent stem cells (PCs) into neural progenitor cells and purified populations of motor neurons. These cells will initially be used in the Company's core drug discovery and toxicology platform. The Company is also exploring therapeutic applications of these cells.

Dr. James Kelly, CEO of Stem Cell Innovations, Inc. (SCI), stated, "These cells have significant potential in both drug discovery and cell therapies to treat diseases such as ALS, Parkinson's, Huntington's, Multiple Sclerosis, and Spinal Cord Injury. Obtaining and protecting neural progenitor cells, as well as purified populations of motor neurons from our PCs, is a significant step for the company." Kelly added, "We are already in discussions with companies that have expressed interest in these cells."

Other stocks highlighted include Conexant Systems, Inc. (NASDAQ: CNXT): Hot Stocks List, up 3% on 43 million shares, Intuitive Surgical, Inc. (NASDAQ: ISRG): Hot Stocks List, down 4% on 3 million shares, Nektar Therapeutics (NASDAQ: NKTR): Hot Stocks List, up 1% on 1 million shares.

"A few disappointing earnings releases and some disparate economic data have done their part to stall the market's advance, and political developments abroad have kept investors cautious. But overall tame inflation numbers, though rising over the past few months, solid growth in the domestic economy, and lower unemployment are buffeting the averages from below." More is available at: http://www.thesubway.com

TheSUBWAY.com's Daily Stock Updates:

TheSUBWAY.com, a leader in corporate communications and finance, highlights stocks that are in the news, have traded high volume, or experienced a large change in price in recent sessions. The aforementioned commentary is not meant to be indicative of a "long term" view of any of the companies listed. For more go to http://www.thesubway.com .

All material herein was prepared by Capital Research Group, Inc. (CRG) based upon information believed to be reliable. The information contained herein is not guaranteed by CRG to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. CRG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.thesubway.com or mentioned herein. CRG has been compensated by third party shareholders or with cash from the company on behalf of one or more of the companies mentioned in this opinion. CRG has been compensated fifty thousand dollars for SCLL. CRG intends to sell its shares. CRG has sold approximately zero SCLL shares to date. CRG may sell its shares for less than the target price given in this opinion. In addition to any compensation mentioned above, additional compensation can be equal to ten percent of any newly issued or registered securities of the profiled companies. CRG's affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. CRG will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

Chuck Tamburello Phone: 954-217-8555 Fax: 954-217-1500